QR kód

Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system

Quadrivalent influenza vaccines (QIVs) are designed to prevent influenza disease caused by two influenza A viruses (H1N1 and H3N2) and both influenza B lineages. Risk-monitoring of QIVs to identify adverse events (AEs) is necessary as influenza vaccines are reformulated each year. We developed a new...

Celý popis

Uloženo v:
Hlavní autoři: Miguel Betancourt-Cravioto, Patricia Cervantes-Powell, Roberto Tapia-Conyer, Shaleesa Ledlie, Sonja Gandhi-Banga
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis Group 2022-01-01
Edice:Human Vaccines & Immunotherapeutics
Témata:
influenza vaccines
vaccination
safety
post-marketing safety surveillance
seasonal influenza
risk management plan
adverse events
pharmacovigilance
immunization
On-line přístup:http://dx.doi.org/10.1080/21645515.2021.1935170
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky